Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1992

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

A multicenter efficacy and safety study of an oral contraceptive containing

150 micrograms desogestrel and 30 micrograms ethinyl estradiol.

AUTHORS

Walling M

SOURCE

CONTRACEPTION. 1992 Oct;46(4):313-26.

ABSTRACT

This multicenter efficacy and safety study was conducted to support US registration of an oral contraceptive (OC)

containing 150 mcg desogestrel and 30 mcg ethinyl estradiol. A total of 11,656 cycles of exposure were

accumulated, corresponding to about 879 women-years of use. The absence of any method failure confirms its high

contraceptive efficacy. The product was generally well tolerated with excellent cycle control, causing fewer than 2%

of the subjects to discontinue because of bleeding irregularities. The study medication demonstrated no adverse

effects on cervical cytology, blood pressure, body weight or laboratory variables, while pre-existing benign breast

disease generally improved. Furthermore, the study did not identify any medication-related adverse experiences. In

conclusion, a monophasic OC with 150 mcg desogestrel and 30 mcg ethinyl estradiol is a safe and effective OC with

excellent cycle control and patient acceptability. (PubHealth.info Document ID: CONT3T 1560-06)

PubHealth.info NOTE: The author(s) of this article titled, "A multicenter efficacy and safety study of an oral

contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol.", is(are) Walling M. The

source of this article is "CONTRACEPTION. 1992 Oct;46(4):313-26.". This article was published in 1992 in English

language(s). (PubHealth.info® Document ID: CONT3T 1560-06. All rights reserved with PubHealth.info) PIN: 11560

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.